Today: 7 March 2026
Subscribe
Browse Category

Stock Market 9 February 2026

BlackRock stock price jumps as Deutsche Bank plugs HausFX into Aladdin

BlackRock stock price jumps as Deutsche Bank plugs HausFX into Aladdin

BlackRock shares climbed 2.5% to $1,083.31 in late trading Monday after the company announced an Aladdin-HausFX integration with Deutsche Bank to automate FX workflows. The firm also reorganized seven municipal closed-end funds into three, adopting a discount management program. Investors are watching for CFO Martin Small’s appearance Tuesday and key U.S. economic data later this week.
9 February 2026
·····
PayPal stock price rebounds as Cantor slashes target and Wall Street looks to CEO handover

PayPal stock price rebounds as Cantor slashes target and Wall Street looks to CEO handover

PayPal shares rose 1.7% to $41.12 Monday after Cantor Fitzgerald cut its 12-month price target to $42 and maintained a neutral rating. The move follows last week’s leadership shakeup, with Enrique Lores set to take over as CEO March 1. PayPal’s recent earnings missed estimates, and branded checkout growth slowed amid tougher competition. Investors remain uncertain about the company’s turnaround prospects.
9 February 2026
·
Amgen stock drops nearly 2% as Dow drag builds — what AMGN investors watch next

Amgen stock drops nearly 2% as Dow drag builds — what AMGN investors watch next

Amgen shares dropped 1.8% to $377.28 in mid-afternoon trading Monday, weighing on the Dow Jones Industrial Average. The decline followed news of an FDA request to withdraw rare-disease drug Tavneos and a sharp 48% fall in Enbrel sales last quarter. Broader drug stocks lagged while traders awaited key U.S. jobs and inflation data later in the week.
9 February 2026
····
Coca-Cola stock price slips despite Wells Fargo target hike as KO earnings loom

Coca-Cola stock price slips despite Wells Fargo target hike as KO earnings loom

Coca-Cola shares fell 1.2% to $78.08 Monday as consumer staples lagged a tech-led rebound. Wells Fargo raised its price target on Coca-Cola to $87, maintaining an “overweight” rating ahead of Tuesday’s earnings. Investors await signals on demand and pricing, with options traders bracing for a 3% swing. Broader markets focused on upcoming U.S. jobs and inflation data.
9 February 2026
··
Teradyne stock rises as chip-test names rebound; traders scan downgrades and U.S. data

Teradyne stock rises as chip-test names rebound; traders scan downgrades and U.S. data

Teradyne shares climbed 3.3% to $309.95 in Monday afternoon trading, following a volatile session and a 60% gain year-to-date. President Capital Management downgraded the stock to neutral but raised its price target to $308. Investors await U.S. jobs and inflation data later this week, which could affect rate-cut expectations. Teradyne’s next dividend record date is February 13.
9 February 2026
··
Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp shares jumped 7.2% to $244.13 Monday after Bank of America raised its price target to $250, maintaining a Neutral rating. The move followed volatile trading after earnings and comes as investors focus on AI-driven optical demand and upcoming U.S. inflation data. Other optical stocks also gained. Coherent forecast third-quarter revenue of $1.70–$1.84 billion and non-GAAP EPS of $1.28–$1.48.
9 February 2026
····
Applied Digital stock jumps nearly 10% as AI data-center trade rebounds; what’s next for APLD

Applied Digital stock jumps nearly 10% as AI data-center trade rebounds; what’s next for APLD

Applied Digital shares jumped 9.6% to $38.32 Monday afternoon, swinging between $33.48 and $39.33 on heavy volume. No new company news was posted. About a third of the float was sold short as of mid-January, heightening volatility. Traders are eyeing U.S. payrolls and CPI data later this week for further market direction.
9 February 2026
···
Philip Morris (PM) stock price slips today despite fresh target hikes as Zyn battle stays in view

Philip Morris (PM) stock price slips today despite fresh target hikes as Zyn battle stays in view

Philip Morris International shares fell 1.4% to $180.17 in Monday afternoon trading after a new debt shelf filing and recent earnings guidance. Investors focused on competition in nicotine pouches and upcoming U.S. economic data. The stock traded between $179.85 and $182.54, about 1.6% below its 52-week high. Several analysts raised their price targets following the company’s updated 2026 outlook.
9 February 2026
·
Arrowhead Pharmaceuticals stock swings as S&P MidCap 400 move lands and Goldman flags 2026 catalysts (ARWR)

Arrowhead Pharmaceuticals stock swings as S&P MidCap 400 move lands and Goldman flags 2026 catalysts (ARWR)

Arrowhead Pharmaceuticals shares fell 0.7% to $64.10 in afternoon trading Monday after moving from the S&P SmallCap 600 to the S&P MidCap 400. The stock saw heavy volume and a wide intraday range. Goldman Sachs maintained a Neutral rating and $85 target, citing key 2026 pipeline data and competition from Ionis Pharmaceuticals. Arrowhead recently reported Q1 revenue of $264 million and 22 cents EPS.
9 February 2026
··
Microchip stock drops on $600 million convertible-notes plan — what investors watch next

Microchip stock drops on $600 million convertible-notes plan — what investors watch next

Microchip Technology shares fell about 2% to $74.52 after the company announced a $600 million convertible notes offering. Proceeds will fund capped-call hedges and repay commercial paper borrowings. The notes mature in 2030 and will be sold privately to institutional buyers. Traders are watching for final pricing and hedging flows that could move the stock.
9 February 2026
··
Merck stock drops nearly 4%: why MRK is lagging the market today

Merck stock drops nearly 4%: why MRK is lagging the market today

Merck shares fell 3.9% to $117.16 Monday, underperforming the broader market as investors weighed patent risks and 2026 earnings guidance. Amgen, Pfizer, and AbbVie also declined. Merck last week projected 2026 sales of up to $67 billion and warned of a $2.5 billion hit from generic competition and weaker COVID-19 drug sales. The Dow lagged as Merck and Amgen dragged on the index.
9 February 2026
··
1 … 112 113 114 115 116 … 1,338
Go toTop